Baird Medical Investment Holdings Limited (BDMD) Earnings History
Annual and quarterly earnings data from 2019 to 2024
Loading earnings history...
BDMD EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
BDMD Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2024 | 88.2% | 41.4% | 33.6% |
| 2023 | 86.6% | 37.7% | 33.5% |
| 2022 | 79.9% | 38.8% | 35.8% |
| 2021 | 83.6% | 43.0% | 42.1% |
| 2020 | 86.1% | 54.4% | 39.2% |
Download Data
Export BDMD earnings history in CSV or JSON format
Free sign-in required to download data
Baird Medical Investment Holdings Limited (BDMD) Earnings Overview
As of May 8, 2026, Baird Medical Investment Holdings Limited (BDMD) reported trailing twelve-month net income of $12M, reflecting +19.5% year-over-year growth. The company earned $0.49 per diluted share over the past four quarters, with a net profit margin of 33.6%.
Looking at the long-term picture, BDMD's historical earnings data spans multiple years. The company achieved its highest annual net income of $13M in fiscal 2022.
Baird Medical Investment Holdings Limited maintains industry-leading profitability with a gross margin of 88.2%, operating margin of 41.4%, and net margin of 33.6%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including NVCR (-$173M net income, -20.8% margin), ARAY (-$46M net income, -0.3% margin), AEYE (-$3M net income, -7.6% margin), BDMD has outperformed on profitability metrics. Compare BDMD vs NVCR →
BDMD Earnings vs Peers
Earnings metrics vs comparable public companies
BDMD Historical Earnings Data (2019–2024)
6 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $12M | +18.1% | $15M | $0.49 | 33.6% | 41.4% |
| 2023 | $11M | -16.1% | $12M | $0.41 | 33.5% | 37.7% |
| 2022 | $13M | +7.6% | $14M | $0.02 | 35.8% | 38.8% |
| 2021 | $12M | +64.5% | $12M | $-0.02 | 42.1% | 43.0% |
| 2020 | $7M | +198.8% | $10M | $0.99 | 39.2% | 54.4% |
| 2019 | -$7M | - | $6M | $-1.00 | -58.8% | 45.9% |
See BDMD's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs BDMD Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare BDMD vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonBDMD — Frequently Asked Questions
Quick answers to the most common questions about buying BDMD stock.
Is BDMD growing earnings?
BDMD EPS is $0.49, with earnings growth accelerating to +19.5%. This exceeds the 5-year CAGR of N/A. TTM net income reached $12M.
What are BDMD's profit margins?
Baird Medical Investment Holdings Limited net margin is +33.6%, with operating margin at +41.4%. Above-average margins indicate pricing power.
How consistent are BDMD's earnings?
BDMD earnings data spans 2019-2024. The accelerating earnings trend is +19.5% YoY. Historical data enables comparison across business cycles.